Koyfin Home > Directory > Health Care > Intra-Cellular Ther

Intra-Cellular Ther Price Chart ITCI

Historical daily share price chart and data for Intra-Cellular Ther since 2013 adjusted for splits and dividends. The latest closing price for Intra-Cellular Ther as of October 28, 2020 is $23.34.
  • In 2020 the stock opened at $34.30 and closed at $23.34 for a loss of -47% YTD.
  • In 2019 the stock opened at $11.12 and closed at $34.31 for a gain of 68%.
  • In 2018 the stock opened at $14.63 and closed at $11.39 for a loss of -28%.
  • In 2017 the stock opened at $15.36 and closed at $14.48 for a loss of -6%.
View Chart On Koyfin

Intra-Cellular Ther Summary

Stock Symbol: ITCI

Intra-Cellular Ther Company Info

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. The company is developing its lead drug candidate, CAPLYTA for the treatment of schizophrenia, bipolar disorder, behavioral disturbances associated with dementia, autism, and other CNS diseases. It is also developing ITI-002 that inhibits the enzyme phosphodiesterase type 1; ITI-214 for Parkinson’s disease; and ITI-333, for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. is headquartered in New York, New York.
Market Cap
1.8b
Dividend Yield
0 %
Beta vs SPX
1.08
Short Interest
589.8 %
30D Volatility
54.44
Hedge Fund Held
0 %
Competitors

Last 10 Days of ITCI Prices

10/28/2020$23.34
10/27/2020$24.02
10/26/2020$24.86
10/23/2020$26.10
10/22/2020$25.75
10/21/2020$24.97
10/20/2020$25.74
10/19/2020$26.04
10/16/2020$26.34
10/15/2020$26.85